S Goldwurm
Overview
Explore the profile of S Goldwurm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
783
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balestrino R, Martone T, Toffoli M, Montanaro E, Fabbri M, Artusi C, et al.
Neurol Sci
. 2023 Nov;
45(4):1489-1497.
PMID: 37926749
Background: Levodopa-carbidopa intestinal gel infusion (LCIG) is a therapeutic option for advanced Parkinson disease (PD) patients with troublesome motor complications, unresponsive to conventional oral treatment. There is some evidence to...
2.
Srulijes K, Hauser A, Guella I, Asselta R, Brockmann K, Schulte C, et al.
Eur J Neurol
. 2013 Mar;
20(4):e61-2.
PMID: 23490118
No abstract available.
3.
Ruffmann C, Giaccone G, Canesi M, Bramerio M, Goldwurm S, Gambacorta M, et al.
Neuropathol Appl Neurobiol
. 2011 Sep;
38(4):382-6.
PMID: 21883375
No abstract available.
4.
Borroni B, Goldwurm S, Cerini C, Cosseddu M, Meucci N, Mariani C, et al.
Eur J Neurol
. 2010 May;
18(1):195-7.
PMID: 20482608
Background: Studies on familial aggregation might be of help to evaluate whether the genetic background has a key role in Progressive Supranuclar Palsy (PSP) and Corticobasal Syndrome (CBS). Only a...
5.
Sironi F, Primignani P, Goldwurm S
Parkinsonism Relat Disord
. 2010 Mar;
16(5):360-1.
PMID: 20227322
No abstract available.
6.
Tobin J, Latourelle J, Lew M, Klein C, Suchowersky O, Shill H, et al.
Neurology
. 2008 May;
71(1):28-34.
PMID: 18509094
Background: Microtubule-associated protein tau (MAPT) has been associated with several neurodegenerative disorders including forms of parkinsonism and Parkinson disease (PD). We evaluated the association of the MAPT region with PD...
7.
Haugarvoll K, Rademakers R, Kachergus J, Nuytemans K, Ross O, Gibson J, et al.
Neurology
. 2008 Mar;
70(16 Pt 2):1456-60.
PMID: 18337586
Objective: Leucine-rich repeat kinase 2 (LRRK2) mutations are the most common cause of Parkinson disease (PD). Several dominantly inherited pathogenic substitutions have been identified in different domains of the Lrrk2...
8.
Di Fonzo A, Chien H, Socal M, Giraudo S, Tassorelli C, Iliceto G, et al.
Neurology
. 2007 May;
68(19):1557-62.
PMID: 17485642
Objective: To assess the prevalence, nature, and associated phenotypes of ATP13A2 gene mutations among patients with juvenile parkinsonism (onset <21 years) or young onset (between 21 and 40 years) Parkinson...
9.
Goldwurm S, Zini M, Mariani L, Tesei S, Miceli R, Sironi F, et al.
Neurology
. 2007 Jan;
68(14):1141-3.
PMID: 17215492
We report the results of a family-based study of LRRK2 G2019S penetrance in Parkinson disease. We studied 19 families identified through the analysis of unrelated consecutive patients. The cumulative incidence...
10.
Wilk J, Tobin J, Suchowersky O, Shill H, Klein C, Wooten G, et al.
Neurology
. 2006 Dec;
67(12):2206-10.
PMID: 17190945
Background: Polymorphisms in the glutathione S-transferase pi gene (GSTP1), encoding GSTP1-1, a detoxification enzyme, may increase the risk of Parkinson disease (PD) with exposure to pesticides. Using the GenePD Study...